Drug Profile
Research programme: cellular adhesion molecule inhibitors - Molecumetics
Alternative Names: Research programme: VCAM/VLA4 - MolecumeticsLatest Information Update: 19 Sep 2006
Price :
$50
*
At a glance
- Originator Molecumetics
- Class Small molecules
- Mechanism of Action Vascular cell adhesion molecule inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 29 Oct 1999 This programme is available for licensing (http://www.molecumetics.com)
- 08 Sep 1999 Preclinical development for Asthma in USA (unspecified route)